Switglim MV 1/500/0.3 Diabetes Tablets 15
Rs. 196.78
Title
Switglim MV 1/500/0.3 Diabetes Tablets 15
Prescription drug
Expiry
:
31-03-2027
AboutSwitglim MV combines Glimepiride, Metformin and Voglibose for Type 2 diabetes management when three-drug therapy is prescribed.Usage InstructionsTake with meals and exactly as prescribed. Swallow whole with water unless the pack specifies another method. Do not skip meals and monitor glucose as advised.BenefitsHelps control fasting and after-meal blood glucose through three complementary antidiabetic mechanisms.How it WorksGlimepiride increases insulin release, Metformin decreases liver glucose production and Voglibose slows intestinal carbohydrate digestion, reducing post-meal glucose rises.Side EffectsLow blood sugar, gas, abdominal discomfort, diarrhoea, nausea and bloating may occur. Seek urgent care for severe hypoglycaemia, persistent vomiting or unusual weakness.Safety AdvicePrescription use only. Tell the doctor about kidney or liver disease, intestinal disorders, pregnancy, breastfeeding and alcohol intake. Keep glucose tablets or another fast-acting sugar source available if advised. Do not use during severe illness or fasting without medical guidance.StorageStore below 30°C in a cool, dry place protected from moisture and light. Keep in the original blister and out of reach of children.
₹196.78
MRP: ₹207.14
Save ₹10.36
(5%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
AboutSwitglim MV combines Glimepiride, Metformin and Voglibose for Type 2 diabetes management when three-drug therapy is prescribed.Usage InstructionsTake with meals and exactly as prescribed. Swallow whole with water unless the pack specifies another method. Do not skip meals and monitor glucose as advised.BenefitsHelps control fasting and after-meal blood glucose through three complementary antidiabetic mechanisms.How it WorksGlimepiride increases insulin release, Metformin decreases liver glucose production and Voglibose slows intestinal carbohydrate digestion, reducing post-meal glucose rises.Side EffectsLow blood sugar, gas, abdominal discomfort, diarrhoea, nausea and bloating may occur. Seek urgent care for severe hypoglycaemia, persistent vomiting or unusual weakness.Safety AdvicePrescription use only. Tell the doctor about kidney or liver disease, intestinal disorders, pregnancy, breastfeeding and alcohol intake. Keep glucose tablets or another fast-acting sugar source available if advised. Do not use during severe illness or fasting without medical guidance.StorageStore below 30°C in a cool, dry place protected from moisture and light. Keep in the original blister and out of reach of children.